2020
DOI: 10.1016/j.omtm.2019.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Adeno-Associated Viral Vectors in Neuroscience Research

Abstract: Adeno-associated viral vectors (AAVs) are increasingly useful preclinical tools in neuroscience research studies for interrogating cellular and neurocircuit functions and mapping brain connectivity. Clinically, AAVs are showing increasing promise as viable candidates for treating multiple neurological diseases. Here, we briefly review the utility of AAVs in mapping neurocircuits, manipulating neuronal function and gene expression, and activity labeling in preclinical research studies as well as AAV-based gene … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
59
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 91 publications
(69 citation statements)
references
References 169 publications
(406 reference statements)
2
59
0
1
Order By: Relevance
“…We overexpressed the TAC1 gene, which gives rise to multiple tachykinins products [reviewed here (Atanasova & Reznikov, 2018)]. While the AAV‐2.1 serotype used in this study has a natural tropism for neurons (Haggerty et al, 2020), other cells are likely to be transduced (Yan et al, 2013). Therefore, the TAC1 gene will be under cell‐type specific regulation.…”
Section: Discussionmentioning
confidence: 99%
“…We overexpressed the TAC1 gene, which gives rise to multiple tachykinins products [reviewed here (Atanasova & Reznikov, 2018)]. While the AAV‐2.1 serotype used in this study has a natural tropism for neurons (Haggerty et al, 2020), other cells are likely to be transduced (Yan et al, 2013). Therefore, the TAC1 gene will be under cell‐type specific regulation.…”
Section: Discussionmentioning
confidence: 99%
“…Several AAV clinical trials were already undergoing for Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, etc. [ 120 ]. The serotype of AAV most widely used in clinical trial is AAV2 that work well in the CNS but with poor infection efficiency in DRG [ 121 , 122 ].…”
Section: Current Challenges To Manipulate On Drg In In Vivo Modelsmentioning
confidence: 99%
“…Ectopic gene overexpression mediated through viral vector delivery is a popular strategy to investigate neuronal gene regulation (Lentz et al, 2012;Haggerty et al, 2020). As previously described, numerous CRISPRa systems have been developed, enabling the potent activation of multiple genes in various tissues types.…”
Section: Regulating Transcription In Vivo With Dcas9mentioning
confidence: 99%